Global In Vivo Electroporation Instrument Market is estimated to be US$ 230.43 million by 2030 with a CAGR of 6.1% during the forecast period

Download Sample

Published Date: July 2023

The Global In-Vivo Electroporation Instrument Market accounted for US$ 128 Million 2020 and is estimated to be US$ 230.43 million by 2030 and is anticipated to register a CAGR of 6.1%. Electroporation is a biotechnological procedure that involves passing an electric current through a live surface, such as a cell or a molecule. Pores emerge on the surface of the living structure in this fashion, allowing biological material to pass through readily. This method is commonly used to introduce viruses or plasmids into cells via pores in the cell membrane in the form of vectors or plasmids. . Electroporation of the cell membrane occurs when cells are exposed to an electric field, and it has been researched and employed in a variety of applications in medicine and food biotechnology (e.g. electrochemotherapy, gene electrotransfer, extraction of biomolecules). Electroporation in vivo has become a popular method for creating nonviral gene treatments and nucleic acid vaccinations (NAV).

The report “Global In Vivo Electroporation Instrument Market, By Application (Biomedical research and Therapeutics), By End-user (Biotechnology and Pharmaceuticals company, Hospital, Academic Research and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”

Key Highlights:

In June 2021, Mirai Medical Ltd, a manufacturer of a precision cancer therapy platform, announced the first procedures at Rigshospitalet, University of Copenhagen, Denmark in a clinical trial to evaluate the safety of Calcium electroporation treatment with EndoVE®, and ePORE® a novel breakthrough technology that can treat gastrointestinal cancers endoscopically.
In July 2021, Inovio Pharmaceuticals discovers, develops, and delivers a new generation of diseases, called DNA vaccines, focused on cancers and infectious diseases. The company's electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake.

Analyst View:

Technological advancements and R&D activities have played an imperative role in bringing about groundbreaking changes across the healthcare sector. The entry of new technologies has paved the way for cutting-edge medical devices that are increasingly being used to treat an array of medical diseases and conditions. As advancements in gene-editing techniques occur at a consistent pace, the prospects of the electroporation instruments market continue to stare at a bright future. Furthermore, with considerable growth in the research and development expenditure, electroporation is extensively being used to deliver chemotherapy drugs and gene electro transfer– factors that are expected to boo Furthermore, as electroporation penetrates 3D structures with high levels of efficiency, advanced gene editing techniques are likely to gain further traction in the upcoming decade .

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global In Vivo Electroporation Instrument Market, By Application (Biomedical research and Therapeutics), By End-user (Biotechnology and Pharmaceuticals company, Hospital, Academic Research and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”

To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-In-Vivo-Electroporation-Instrument-Market-4731

Key Market Insights from the report:

The Global Biometric Sensors Market accounted for US$ 128 Million 2020 and is estimated to be US$ 230.43 million by 2030 and is anticipated to register a CAGR of 6.1%.The Global In vivo Electroporation Instrument Market is segmented based on the application, end-users, and region.

By Application type, the Global In Vivo Electroporation Instrument Market is segmented into Biomedical research and Therapeutics.
By End-user, the target market is segmented into Biotechnology and Pharmaceuticals Company, Hospital, Academic research and Others.
By Region, the Global In Vivo Electroporation Instrument Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Presence of highly modern research facilities and diagnostic clinics, North America is expected to have the biggest market share for electroporation instruments.

Competitive Landscape:

The key players operating in the global In vivo electroporation instrument market includes Thermo Fisher Scientific, Inc., Merck, Lonza group, BEX, Celetrix LLC., Eppendorf AG, Harvard Bioscience Inc., Maxcyte Inc., Mirus Bio LLC, and Bio Rad laboratories. The companies are focusing on acquisitions and collaboration strategies to strengthen its market, which is expected to fuel the markets growth.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period